Testing effectiveness (Phase 2)Ended earlyNCT04024436
What this trial is testing
TAS-120 in Patients With Metastatic Breast Cancer
Who this might be right for
Metastatic Breast CancerFGFR 1 High AmplificationFGFR2 Amplification
Taiho Oncology, Inc. 64